Multiple sclerosis: Immunopathological heterogeneity and its implications

Abstract: MS is the most common autoimmune demyelinating disease of the CNS. For the past decades, several immunomodulatory disease‐modifying treatments with multiple presumed mechanisms of action have been developed, but MS remains an incurable disease. Whereas high efficacy, at least in early disease, corroborates underlying immunopathophysiology, there is profound heterogeneity in clinical presentation as well as immunophenotypes that may also vary over time. In addition, functional plasticity in the immune system as well as in the inflamed CNS further contributes to disease heterogeneity. In this review, we will highlight immune‐pathophysiological and associated clinical heterogeneity that may have an implication for more precise immunomodulatory therapeutic strategies in MS.

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
Multiple sclerosis: Immunopathological heterogeneity and its implications ; day:06 ; month:05 ; year:2022 ; extent:13
European journal of immunology ; (06.05.2022) (gesamt 13)

Creator
Engelhardt, Britta
Comabella, Manuel
Chan, Andrew

DOI
10.1002/eji.202149757
URN
urn:nbn:de:101:1-2022050715072732768661
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:28 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

Other Objects (12)